Related Experiment Video
Updated: Aug 9, 2026

Visualization of Bacterial Resistance using Fluorescent Antibiotic Probes
Published on: March 2, 2020
The role of fluoroquinolones in respiratory tract infections
1Division of Respiratory Medicine, Mount Sinai Hospital, Toronto, Canada.
Abstract:
Quinolones, because of their excellent pharmacokinetic properties, high antimicrobial activity and low incidence of side-effects, have been broadly accepted for the treatment of many infections. Because of perceived limitations against Streptococcus pneumoniae and methicillin-resistant Staphylococcus aureus there has been some reluctance to use them for respiratory tract infections. Ciprofloxacin is the drug of choice for malignant external otitis, a disease caused by Pseudomonas aeruginosa, and it has also been used successfully for the treatment of chronic otitis media where P. aeruginosa, S. aureus and Proteus mirabilis are main pathogens. Quinolones are as efficacious as the beta-lactams and cephalosporins in the treatment of acute sinusitis but most clinicians will not use quinolones for this indication. Acute bacterial exacerbations of chronic bronchitis respond to antimicrobial therapy and quinolones have been demonstrated to be at least equivalent to second- and third-generation cephalosporins, co-amoxiclav and beta-lactams. Recently published guidelines in Canada, USA and Great Britain do not recommend quinolones for the treatment of community-acquired pneumonia except for patients with life-threatening disease requiring ICU admission. A quinolone in combination with an aminoglycoside and macrolide is a regimen that can be used as initial empirical therapy until the results of microbiological investigations are available. For patients with severe hospital-acquired pneumonia, where multiply resistant aerobic Gram-negative bacilli are a consideration, a quinolone in combination with an antipseudomonal penicillin or cephalosporin has been recommended. In the absence of P. aeruginosa, monotherapy with a quinolone is at least as effective as third-generation cephalosporins or imipenem. Early switch therapy from parenteral antibiotics to oral fluoroquinolone has been demonstrated to be very successful.
Insights
Quinolones are effective antibiotics for various infections, including otitis media and bronchitis. Despite some reluctance for respiratory infections, they show comparable efficacy to other treatments and are valuable for severe pneumonia and switch therapy.
Area of Science:
- Pharmacology
- Infectious Diseases
- Antimicrobial Therapy
Background:
- Quinolones are widely accepted for treating infections due to favorable pharmacokinetics, high antimicrobial activity, and low side-effect incidence.
- Despite their benefits, reluctance exists in using quinolones for respiratory tract infections due to perceived limitations against Streptococcus pneumoniae and methicillin-resistant Staphylococcus aureus.
Purpose of the Study:
- To evaluate the efficacy and application of quinolones in treating various bacterial infections.
- To address the reluctance in using quinolones for specific indications like respiratory tract infections and sinusitis.
- To review the role of quinolones in managing community-acquired and hospital-acquired pneumonia.
Main Methods:
- Review of existing literature and clinical guidelines regarding quinolone use.
- Comparison of quinolone efficacy against other antibiotic classes (beta-lactams, cephalosporins) in different infections.
- Analysis of quinolone application in specific conditions such as malignant external otitis, chronic otitis media, sinusitis, bronchitis, and pneumonia.
Main Results:
- Ciprofloxacin is effective for malignant external otitis and chronic otitis media caused by Pseudomonas aeruginosa, Staphylococcus aureus, and Proteus mirabilis.
- Quinolones demonstrate equivalent efficacy to beta-lactams and cephalosporins in acute sinusitis and acute bacterial exacerbations of chronic bronchitis.
- Current guidelines recommend quinolones for severe community-acquired pneumonia and hospital-acquired pneumonia, often in combination therapy, and support early switch to oral fluoroquinolones.
Conclusions:
- Quinolones are highly effective and versatile antimicrobials with a broad spectrum of activity.
- Their use in respiratory tract infections and sinusitis is supported by evidence of efficacy comparable to standard treatments.
- Quinolones play a crucial role in managing severe pneumonia and facilitate successful early switch therapy from parenteral to oral administration.
Related Concept Videos
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Gene Regulation in Microbial Communities: Quorum Sensing
Microbiota of the Respiratory Tract
Mechanism of Antibiotic Resistance in MRSA
Influenza
Inhibitors of Bacterial DNA Synthesis

